Synbio Tech Inc. (TPEX:1295)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
76.90
+1.60 (2.12%)
Feb 11, 2026, 1:04 PM CST
Market Cap2.60B +11.1%
Revenue (ttm)1.00B +2.6%
Net Income155.61M -13.5%
EPS4.77 -16.6%
Shares Out34.48M
PE Ratio15.77
Forward PE10.22
Dividend3.50 (4.61%)
Ex-Dividend DateMar 27, 2025
Volume66,649
Average Volume74,912
Open79.70
Previous Close75.30
Day's Range75.80 - 79.70
52-Week Range58.50 - 157.50
Beta1.23
RSI32.62
Earnings DateMar 27, 2026

About Synbio Tech

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improve digestive and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 92
Stock Exchange Taipei Exchange
Ticker Symbol 1295
Full Company Profile

Financial Performance

In 2024, Synbio Tech's revenue was 989.48 million, an increase of 20.18% compared to the previous year's 823.30 million. Earnings were 170.13 million, an increase of 50.19%.

Financial Statements